Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible
In Brief: Gallo Signs Agreement With Univ. of Maryland; Donor Gives $5 Million To San Diego Center
Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study
DCPC Advisors Okay New Grant Programs To Improve Participation Of Women, Minorities In Clinical Trials
National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









